Thrombomimetic agents in myelodysplastic syndromes and Q&A
. Cherif H. 05/20/11; 7651
Disclosure(s): Grants/Research Support:Pfizer, Bristol Myers Squibb, GSK; Advisory Boards: Amgen, GSK, Wyeth; Speakers Bureau: Celgene, Wyeth, Amgen, Pfizer; Medical Advisor: Wyeth Farmaceuticals
CLICK HERE TO LOGIN
REGULAR CONTENT
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}